This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by Rosenblum, M. G. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by Rosenblum, M. G.

¹ Immunopharmacology and Targeted Therapy Section, Department of Bioimmunotherapy and ² Department of Experimental Therapeutics, M. D. Anderson Cancer Center, Houston, TX

Requests for Reprints: Michael G. Rosenblum, Immunopharmacology and Targeted Therapy Section, Department of Bioimmunotherapy, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 44, Houston, TX 77030. Phone: (713) 792-3554; Fax: (713) 794-4261. E-mail: mrosenbl{at}notes.mdacc.tmc.edu

The serine protease granzyme B (GrB, 25 kDa) can initiate apoptosis by multiple mechanisms including directly activating caspases, inducing DNA fragmentation, activating the mitochondrial death pathway, and directly cleaving the nuclear matrix. The purpose of this study was to determine whether a recombinant antibody could deliver sufficient amounts of GrB to target cells to generate an apoptotic signal. The gene sequence encoding GrB was attached to the single-chain anti-melanoma antibody scFvMEL (anti-gp240) via a flexible (G₄S) tether. The 53-kDa GrB/scFvMEL fusion protein was expressed in bacteria and purified by metal affinity chromatography. Western blotting confirmed presence of both scFvMEL and GrB proteins. The fusion construct displayed intact GrB enzymatic activity (specific activity = 2.6 x 10⁵ units/µmol) similar to native GrB (specific activity = 4.8 x 10⁵ units/µmol). The construct bound specifically to human A375-M melanoma cells and delivered GrB to the cytosol as assessed by confocal microscopy. Against log-phase melanoma cells, GrB/scFvMEL demonstrated an IC₅₀ of 20 nM and minimal cytotoxicity to non-target cells at doses of up to 1 µM. Coadministration of exogenous perforin (PFN) to cells resulted in a slight increase in the cytotoxic effects of the GrB/scFvMEL construct on A375 target cells and a significant increase in cytotoxicity to SKBR3 (non-target) cells. The cytotoxic effects of this fusion construct on target cells were similar to those of the previously described MEL sFv/rGel fusion toxin (IC₅₀ 20 nM). The construct produced impressive apoptotic effects by 8 h after treatment of target cells. Mediation of the apoptotic effects of GrB/scFvMEL included caspase-3 cleavage and release of cytochrome c into the cytosolic compartment from the mitochondrial compartment. These studies demonstrate that delivery of the human pro-apoptotic pathway enzyme GrB to tumor cells may have significant therapeutic potential for cancer treatment and represents a new class of targeted therapeutic agents with a defined mechanism of action.

Note: Research conducted, in part, by the Clayton Foundation for Research.

Received 2/ 4/03; revised 9/23/03; accepted 10/ 1/03.

This article has been cited by other articles:

				H. Kashiwagi, J. E. McDunn, P. S. Goedegebuure, M. C. Gaffney, K. Chang, K. Trinkaus, D. Piwnica-Worms, R. S. Hotchkiss, and W. G. Hawkins TAT-Bim Induces Extensive Apoptosis in Cancer Cells Ann. Surg. Oncol., May 1, 2007; 14(5): 1763 - 1771. [Abstract] [Full Text] [PDF]

				H.-Y. Qin, R. Mukherjee, E. Lee-Chan, C. Ewen, R. C. Bleackley, and B. Singh A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity Int. Immunol., July 1, 2006; 18(7): 1001 - 1015. [Abstract] [Full Text] [PDF]

				M. Laforge, N. Bidere, S. Carmona, A. Devocelle, B. Charpentier, and A. Senik Apoptotic Death Concurrent with CD3 Stimulation in Primary Human CD8+ T Lymphocytes: A Role for Endogenous Granzyme B J. Immunol., April 1, 2006; 176(7): 3966 - 3977. [Abstract] [Full Text] [PDF]

				F. C. Kurschus, R. Bruno, E. Fellows, C. S. Falk, and D. E. Jenne Membrane receptors are not required to deliver granzyme B during killer cell attack Blood, March 1, 2005; 105(5): 2049 - 2058. [Abstract] [Full Text] [PDF]